Radiopharmaceuticals for Lymphoscintigraphy: Including dusimetry and radiation considerations
References (41)
- et al.
Cumulative radiation effect. 3. Continous radiation therapy—short-lived sources
Clin Radiol
(1973) - et al.
Cumultive radiation effect. part IV. Normalisation of fractionated and continuous therapy-area and volume correction factors
Clin Radiol
(1975) - et al.
Technetium-sulfurcolloid
Int J Radiat Appl Instrum
(1986) - et al.
Particle sizing and biokinetics of interstital lymphoscintigraphic agents
Semin Nucl Med
(1983) - et al.
Intraoperative lymphatic mapping for early-stage melanoma of the head and neck
An J Surg
(1997) - et al.
Sentinel node localization in breast cancer
Semin Nucl Med
(1999) - et al.
Lymphoscintigraphy with Tc-99m-labeled dextran
J Nucl Med
(1982) - et al.
Radiolabeled colloids and macromolecules in the lymphatic system
Crit Rev Ther Drug Carrier Syst
(1989) - et al.
Quantitative lymphoscintigraphy I. Basic conepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits
J Nucl Med
(1979) - et al.
Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid
J Nucl Med
(1982)
Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma
Radiology
Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscanning
J Nucl Med
Technetium (VII) Compounds
Amersham Product Information: Solco NANOCOLL
Radiopharmaceuticals in sentinel lymph-node detection-an overview
Eur J Nucl Med
Amersham Product Information: ALBU-Res
Preparation and evaluation of Tc-99m hydroxyethyl starch as a potential radiopharmaceutical for lymphoscintigraphy: Comparison with Tc-99m human serum albumin, Tc-99m dextran, and Tc-99m sulfur microcolloid
Lymphology
Optimized sentinel node scintigraphy in breast cancer
Q J Nucl Med
Sentinel node identification with Tc-99m colloidal albumin lymphoscintigraphy and gamma probe guidance in breast cancer
J Nucl Med
Technetium-99m-sulfur colloid for lymphoscintigraphy: Effects of preparation parameters
J Nucl Med
Cited by (85)
Sentinel Lymph Node Identification in Patients With Breast Cancer Using Lymphosonography
2023, Ultrasound in Medicine and BiologyCitation Excerpt :Accurate assessment of potential LN involvement is essential to limit the removal to only the affected LNs as a way to minimize the anatomical disruption caused by an extensive axillary LN removal, which can result in lymphedema, nerve injury, shoulder dysfunction and other complications that may compromise functionality and quality of life (Lyman et al. 2005; Jang et al. 2022). Currently, the lymphatic system is mapped after the injection of blue dye and/or a radioactive tracer followed by a surgical excision (Hill et al. 1999; Eshima et al. 2000; Veronesi et al. 2003; Emerson et al. 2012). This approach has several limitations.
Preliminary evaluation of the potential of <sup>99m</sup>Tc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection
2016, Applied Radiation and IsotopesCitation Excerpt :It should allow for scintigraphic imaging prior to surgery for preliminary localization and subsequent precise in situ detection using a hand-held gamma probe. 99mTc-labeled sulfur colloid and human serum albumin (HSA) nanocolloid are the prominent clinically employed radiotracers for SLN detection (Wilhelm et al., 1999; Eshima et al., 2000). These conventional nanoparticulate tracers are retained upon phagocytosis by the macrophages in the lymph node.
Radiopharmaceuticals for sentinel lymph node identification in breast cancer
2023, Journal of Radioanalytical and Nuclear ChemistrySentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography
2023, Journal of Ultrasound in MedicineSentinel Lymph Node Identification Using Contrast Lymphosonography: A Systematic Review
2023, Advanced Ultrasound in Diagnosis and Therapy